ライム病(Lyme Disease)：世界の治験レビュー2014年下半期版...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Lyme Disease 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Europe 9
Top Countries Contributing to Clinical Trials in North America 10
Clinical Trials by G7 Countries: Proportion of Lyme Disease to Infectious Disease Clinical Trials 11
Clinical Trials by Phase in G7 Countries 12
Clinical Trials in G7 Countries by Trial Status 13
Clinical Trials by Phase 14
In Progress Trials by Phase 15
Clinical Trials by Trial Status 16
Clinical Trials by End Point Status 17
Unaccomplished Trials of Lyme Disease 18
Subjects Recruited Over a Period of Time 19
Clinical Trials by Sponsor Type 20
Prominent Sponsors 21
Top Companies Participating in Lyme Disease Therapeutics Clinical Trials 22
Prominent Drugs 23
Clinical Trial Profiles 24
Clinical Trial Overview of Top Companies 24
Ixodes GmbH 24
Clinical Trial Overview of Ixodes GmbH 24
Baxter International Inc. 25
Clinical Trial Overview of Baxter International Inc. 25
Valneva SE 26
Clinical Trial Overview of Valneva SE 26
Clinical Trial Overview of Top Institutes / Government 27
University Medical Centre Ljubljana 27
Clinical Trial Overview of University Medical Centre Ljubljana 27
The National Institute of Allergy and Infectious Diseases 28
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 28
Sorlandet Hospital HF 29
Clinical Trial Overview of Sorlandet Hospital HF 29
Turku University Hospital 30
Clinical Trial Overview of Turku University Hospital 30
Les Hopitaux Universitaires de Strasbourg 31
Clinical Trial Overview of Les Hopitaux Universitaires de Strasbourg 31
University of Zurich 32
Clinical Trial Overview of University of Zurich 32
University of Oslo 33
Clinical Trial Overview of University of Oslo 33
National Institute of Neurological Disorders and Stroke 34
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 34
University of Minnesota 35
Clinical Trial Overview of University of Minnesota 35
National Institute of Arthritis and Musculoskeletal and Skin Diseases 36
Clinical Trial Overview of National Institute of Arthritis and Musculoskeletal and Skin Diseases 36
Five Key Clinical Profiles 37
Appendix 57
Abbreviations 57
Definitions 57
Research Methodology 58
Secondary Research 58
About GlobalData 59
Contact Us 59
Disclaimer 59
Source 59